Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 74 clinical trials
DEB-TACE+HAIC vs. HAIC for Large HCC

This study is conducted to evaluate the efficacy and safety of transarterial chemoembolization with drug-eluting beads (DEB-TACE) plus hepatic artery infusion chemotherapy (HAIC) compared with

  • 0 views
  • 10 Mar, 2022
  • 1 location
Instylla HES Hypervascular Tumor Pivotal Study

/conventional transarterial chemoembolization, while resulting in an acceptable risk of device and procedure-related serious adverse events.

  • 2 views
  • 19 Feb, 2021
  • 1 location
A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma

This study is a phase II, prospective, single-center, single-arm trial to evaluate the efficacy and safety of the combination of neoadjuvant transcatheter arterial chemoembolization (TACE) and

  • 0 views
  • 09 Jun, 2022
  • 1 location
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC (EMERALD-3)

A global study to evaluate transarterial chemoembolization (TACE) in combination with durvalumab, tremelimumab and lenvatinib therapy in patients with locoregional hepatocellular carcinoma

TACE
measurable disease
  • 0 views
  • 10 Jul, 2022
  • 7 locations
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

The purpose of this study is to evaluate the efficacy and safety of lenvatinib and pembrolizumab in combination with TACE versus TACE plus oral and intravenous (IV) placebos in participants with incurable, non-metastatic hepatocellular carcinoma (HCC). The primary hypotheses are that pembrolizumab plus lenvatinib in combination with TACE is superior …

TACE
lenvatinib
chemoembolization
metastatic hepatocellular carcinoma
hepatitis
  • 91 views
  • 29 Jul, 2022
  • 186 locations
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

The objective of this study is to study the safety and tumor response of ACE for large HCC.

hepatectomy
measurable disease
chemoembolization
cirrhosis
  • 1 views
  • 14 Feb, 2022
  • 1 location
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

This phase II trial studies the effect of transarterial chemoembolization in treating patients with uveal melanoma that has spread to the liver (liver metastases). Transarterial

  • 0 views
  • 26 Oct, 2021
  • 1 location
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma

The purpose of this study is to develop better ways to treat liver cancer, known as hepatocellular carcinoma or HCC, while it is still in the liver. Many treatments exist to treat tumors in the liver when they are small but after they grow past a certain size, local therapies …

cancer
ascites
liver disease
chemoembolization
liver cancer
  • 13 views
  • 27 Jan, 2021
  • 1 location
Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease (LIVERPEARL)

Non-commercial, prospective, randomized, multicenter, national, phase II, open-label comparative clinical trial. The patients will be randomized in a 1: 1 ratio in two arms: Control arm. Systemic chemotherapy with FOLFOX6m + monoclonal Ab Experimental arm. Systemic chemotherapy with FOLFOX6m + monoclonal Ab + Intra-arterial liver chemotherapy with LIFEPEARLS-IRINOTECAN (catheterization and …

  • 0 views
  • 23 Mar, 2022
  • 7 locations
Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

The purpose of this study was to prospectively collect clinical data from patients who underwent hepatic artery chemoembolization using microspheres with different degradation times (2 hours, 1

  • 0 views
  • 27 Apr, 2022
  • 1 location